The coronavirus vaccine that Russia developed is safe and elicited “strong humoral and cellular immune responses” in human trials.
As part of a study published in The Lancet, researchers in Russia detailed their findings based on two trials that involved a total of 76 people between June 18 and Aug. 3.
The vaccine, they wrote, “has a good safety profile and induced strong humoral and cellular immune responses in participants. Further investigation is needed of the effectiveness of this vaccine for prevention of COVID-19.”
Read more at NEWSMAX.